Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients

Markets are flat as investors await Nvidia's earnings, with expectations of strong AI-driven growth fueling anticipation. Trump's attempt to remove Fed Governor Lisa Cook raises concerns about central bank independence and could signal a shift favoring small-cap stocks.

Agnico Eagle Mines Limited (AEM) up 1,004% since Big Money bought big in September 2002.

Calgary, Alberta--(Newsfile Corp. - August 27, 2025) - DevvStream Corp. (NASDAQ: DEVS) (the "Company"), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today announced that on August 22, 2025, it received a notice from The Nasdaq Stock Market, LLC (the "Nasdaq") notifying the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2) and that its common shares, with no par value (the "Common Shares"), continue to be listed and traded on The Nasdaq Capital Market. As previously disclosed, the Company received a staff determination from Nasdaq stating that the bid price …

WILMINGTON, Del., Aug. 27, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced its expanded access policy for NRX-100 (preservative-free ketamine) based on grant of Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, including bipolar depression.

AUSTIN, Texas--(BUSINESS WIRE)--CrowdStrike (NASDAQ: CRWD) today announced it has been named a Leader in the IDC MarketScape: Worldwide Incident Response Services Vendor Assessment. Adversaries are now weaponizing AI to scale operations, accelerate attacks, and target the very AI systems and autonomous agents that are reshaping enterprise environments. Defending against this new era of threats demands partners with deep incident response experience, real-time visibility across diverse systems,.

MongoDB's latest earnings suggest the risk of losing database market share in the artificial-intelligence era might be overblown.

Abercrombie & Fitch narrowly beat Wall Street's expectations thanks to strong growth at its teen-focused Hollister brand. The company's namesake brand's sales fell 5%, while Hollister grew 19%.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing Brands (BRBR) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in BellRing Brands and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company's senior management team will participate in the following investor conferences: Wells Fargo 20 th Annual Healthcare Conference September 4, 20253:00 pm ETWebcast link here One-on-one meetings HCW 27 th Annual Global Investment Conference September 9, 20251:30 PM ETWebcast link here One-on-one meetings Please contact your conference representative to request one-on-one meetings.

BOULDER, Colo. , Aug. 27, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced the appointment of Eric Ruhle as Vice President of Brand Sales, overseeing sales strategy across the full Canopy USA portfolio.

Shares of Nvidia Corp. (NASDAQ: NVDA) have surged 38.4% over the past 90 days, including a 3.6% pop in the past week ahead of its earnings report.

RESEARCH TRIANGLE PARK, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq:IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, today announced that it will present on its IRD gene therapy programs at the following scientific conferences in September 2025.

AUSTIN, Texas,--(BUSINESS WIRE)--YETI Holdings, Inc. (“YETI”) (NYSE: YETI) today announced that management will be attending the Goldman Sachs 32nd Annual Global Retailing Conference on Wednesday, September 3, 2025, in New York, NY. About YETI Holdings, Inc. Headquartered in Austin, Texas, YETI is a global designer, retailer, and distributor of innovative outdoor products. From coolers and drinkware to bags and apparel, YETI products are built to meet the unique and varying needs of diverse out.

NEEDHAM, Mass.--(BUSINESS WIRE)--SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced that the Company will be participating in the following investor conferences in September: On Wednesday, September 3, 2025, the company will be hosting a fireside chat at the Goldman Sachs 32nd Annual Global Retailing Conference in New York, NY. The fireside chat is scheduled to begin at 9:35 a.m. EDT. On Thursday, September 11, 2025, the company will be participating in.

MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC), and its subsidiary, AI Catalysis Corp. (“AI Catalysis”), today announced the upcoming launch of its AI Immersive Reading Platform (the “Platform”), an innovative ecosystem currently in its development and testing stage, designed to redefine how stories are created, shared, and enjoyed. This development marks a major milestone for the Company in interactive storytelling and opens the door for creators worldwide to participate in shaping a new future for digital narratives by joining its founding community.

TAMPA, Fla., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Slide Insurance Holdings, Inc. (“Slide” or the “Company”) (Nasdaq: SLDE) today announced that its Board of Directors has authorized the repurchase of up to $75 million of the Company's common stock. The authorization is effective immediately, has no time limit, and may be modified, suspended or discontinued at any time.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in the following investor conferences:

BXCL501 achieved SERENITY At-Home's primary endpoint of being well tolerated in the at-home treatment of agitation episodes in patients with bipolar disorders or schizophrenia